<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00257</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Description of test system and test methods.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (i) A description of the general design of the experiment  <!-- PJG 0012 frnewline --> shall be provided. This shall include a short justification  <!-- PJG 0012 frnewline --> explaining any decisions where professional judgment is involved  <!-- PJG 0012 frnewline --> such as fixation technique and choice of stains; and  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ii) Positive control data from the laboratory performing  <!-- PJG 0012 frnewline --> the test that demonstrate the sensitivity of the procedures being  <!-- PJG 0012 frnewline --> used. Historical data may be used if all essential aspects of  <!-- PJG 0012 frnewline --> the experimental protocol are the same.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Results.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All observations shall be recorded and  <!-- PJG 0012 frnewline --> arranged by test groups. This data may be presented in the  <!-- PJG 0012 frnewline --> following recommended format:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (i)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Description of signs and lesions for each animal.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> For  <!-- PJG 0012 frnewline --> each animal, data must be submitted showing its identification  <!-- PJG 0012 frnewline --> (animal number, treatment, dose, duration), neurologic signs,  <!-- PJG 0012 frnewline --> location(s) nature of, frequency, and severity of lesion(s). A  <!-- PJG 0012 frnewline --> commonly-used scale such as 1+, 2+, 3+, and 4+ for degree of  <!-- PJG 0012 frnewline --> severity ranging from very slight to extensive may be used. Any  <!-- PJG 0012 frnewline --> diagnoses derived from neurologic signs and lesions including  <!-- PJG 0012 frnewline --> naturally occurring diseases or conditions, shall also be  <!-- PJG 0012 frnewline --> recorded;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Counts and incidence of lesions, by test group.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Data  <!-- PJG 0012 frnewline --> shall be tabulated to show:  <!-- PJG 0012 frnewline --> (A) The number of animals used in each group, the number of  <!-- PJG 0012 frnewline --> animals displaying specific neurologic signs, and the number of  <!-- PJG 0012 frnewline --> animals in which any lesion was found; and  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (B) The number of animals affected by each different type  <!-- PJG 0012 frnewline --> of lesion, the average grade of each type of lesion, and the  <!-- PJG 0012 frnewline --> frequency of each different type and/or location of lesion.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (iii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Evaluation of data.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (A) An evaluation of the data based on gross necropsy  <!-- PJG 0012 frnewline --> findings and microscopic pathology observations shall be made and  <!-- PJG 0012 frnewline --> supplied. The evaluation shall include the relationship, if any,  <!-- PJG 0012 frnewline --> between the animal's exposure to the test atmosphere and the  <!-- PJG 0012 frnewline --> frequency and severity of any lesions observed; and  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (B) The evaluation of dose-response, if existent, for  <!-- PJG 0012 frnewline --> various groups shall be given, and a description of statistical  <!-- PJG 0012 frnewline --> method must be presented. The evaluation of neuropathology data  <!-- PJG 0012 frnewline --> shall include, where applicable, an assessment in conjunction  <!-- PJG 0012 frnewline --> with any other neurotoxicity studies, electrophysiological,  <!-- PJG 0012 frnewline --> behavioral, or neurochemical, which may be relevant to this  <!-- PJG 0012 frnewline --> study.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (g)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> References.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> For additional background information on  <!-- PJG 0012 frnewline --> this test guideline, the following references should be consulted. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=26 g=1 f=1 --> (1) 40 CFR 798.6400, Neuropathology.  <!-- PJG 0012 frnewline --> (2) AFIP Manual of Histologic Staining Methods. (New York:  <!-- PJG 0012 frnewline --> McGraw-Hill (1968).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (3) Chang, L.W. A Color Atlas and Manual for Applied  <!-- PJG 0012 frnewline --> Histochemistry. (Springfield, IL: Charles C. Thomas, 1979).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (4) Dunnick, J.K., et.al. Thirteen-week Toxicity Study of  <!-- PJG 0012 frnewline --> N-Hexane in B6C3F1 Mice After Inhalation Exposure (1989)  <!-- PJG 0012 frnewline --> Toxicology, 57, 163&hyph;172.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (5) Hayat, M.A. ``Vol. 1. Biological applications,''  <!-- PJG 0012 frnewline --> Principles and techniques of electron microscopy. (New York: Van  <!-- PJG 0012 frnewline --> Nostrand Reinhold, 1970).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (6) Palay S.L., Chan-Palay, V. Cerebellar Cortex: Cytology  <!-- PJG 0012 frnewline --> and Organization. (New York: Springer-Verlag, 1974).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (7) Ralis, H.M., Beesley, R.A., Ralis, Z.A. Techniques in  <!-- PJG 0012 frnewline --> Neurohistology. (London: Butterworths, 1973).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (8) Sette, W. ``Pesticide Assessment Guidelines, Subdivision  <!-- PJG 0012 frnewline --> F, Neurotoxicity Test Guidelines.'' Report No. 540/09&hyph;91&hyph;123 U.S.  <!-- PJG 0012 frnewline --> Environmental Protection Agency 1991 (NTIS  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=6 f=1 --> # <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> PB91&hyph;154617).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (9) Spencer, P.S., Schaumburg, H.H. (eds). Experimental and  <!-- PJG 0012 frnewline --> Clinical Neurotoxicology. (Baltimore: Williams and Wilkins,  <!-- PJG 0012 frnewline --> 1980).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            